| Literature DB >> 33540726 |
Ram B Khattri1, Kyoungrae Kim1, Trace Thome1, Zachary R Salyers1, Kerri A O'Malley2,3, Scott A Berceli2,3, Salvatore T Scali2,3, Terence E Ryan1,4,5.
Abstract
Chronic limb threatening ischemia (CLTI) is the most severe manifestation of peripheral atherosclerosis. Patients with CLTI have poor muscle quality and function and are at high risk for limb amputation and death. The objective of this study was to interrogate the metabolome of limb muscle from CLTI patients. To accomplish this, a prospective cohort of CLTI patients undergoing either a surgical intervention (CLTI Pre-surgery) or limb amputation (CLTI Amputation), as well as non-peripheral arterial disease (non-PAD) controls were enrolled. Gastrocnemius muscle biopsy specimens were obtained and processed for nuclear magnetic resonance (NMR)-based metabolomics analyses using solution state NMR on extracted aqueous and organic phases and 1H high-resolution magic angle spinning (HR-MAS) on intact muscle specimens. CLTI Amputation specimens displayed classical features of ischemic/hypoxic metabolism including accumulation of succinate, fumarate, lactate, alanine, and a significant decrease in the pyruvate/lactate ratio. CLTI Amputation muscle also featured aberrant amino acid metabolism marked by elevated branched chain amino acids. Finally, both Pre-surgery and Amputation CLTI muscles exhibited pronounced accumulation of lipids, suggesting the presence of myosteatosis, including cholesterol, triglycerides, and saturated fatty acids. Taken together, these metabolite differences add to a growing body of literature that have characterized profound metabolic disturbance's in the failing ischemic limb of CLTI patients.Entities:
Keywords: hypoxia; metabolites; metabolomics; myosteatosis; peripheral artery disease; peripheral vascular disease
Year: 2021 PMID: 33540726 PMCID: PMC7867254 DOI: 10.3390/jcm10030548
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241